Deferred registration: Quotient Sciences Code: QSC304473
This early-stage Phase 1 trial is recruiting healthy men aged 30 to 65. The study is run by Quotient Sciences, a UK clinical research organisation. In Phase 1 studies, doctors test a potential new medicine in a small group of people to check its safety, observe side effects, and see how the body processes it. The trial has a 'deferred registration'. This is a standard process that temporarily keeps specific scientific details private to protect research data or patents. Full information will be released publicly on or before an agreed date. Healthy volunteers do not receive medical benefit from the treatment, but their participation helps researchers gather vital safety data before medicines are tested in patients who are ill. Taking part is entirely voluntary, and participants undergo thorough health checks before and during the study.
At a glance
What is this study about?
Phase 1 clinical trials are the first step in testing potential new treatments in humans. Before a medicine can be given to patients living with an illness, researchers must first understand how it works in a healthy body. This study focuses on basic safety, checking how the treatment is absorbed, broken down, and removed by the body, as well as tracking any unwanted side effects.
You may notice that the exact name of the medicine and detailed study goals are marked as 'deferred'. In the UK, research rules allow companies to delay making some commercial details public for a limited time. This protects intellectual property while the early science is completed. However, this does not mean safety standards are reduced. The trial still undergoes strict review by independent UK ethics committees and regulatory authorities before any volunteer takes part.
Studies involving healthy volunteers are essential for medical progress. Every approved prescription medicine available today was first tested in healthy people. By carefully measuring vital signs, blood levels, and general wellbeing, the research team can find safe dose ranges and decide if the treatment is suitable for further research.
Key takeaways
- Phase 1 trial testing safety and how the body handles a new treatment.
- Looking for healthy male volunteers aged between 30 and 65.
- Full scientific details are temporarily withheld under an approved deferral.
- Participation involves medical tests, clinic visits, and possible overnight stays.
- Volunteers can leave the trial at any time without losing any standard rights.
Who may be eligible?
To be considered for this study, you must be a man between the ages of 30 and 65. You must also be in good general health, without major ongoing medical conditions.
While the detailed medical criteria are deferred, Phase 1 studies with healthy volunteers usually require that you do not take regular prescription medicines. You will likely need to have normal blood pressure, a healthy body weight, and normal blood and urine test results.
You may not be eligible if you smoke, use recreational drugs, have a history of serious illness, or have recently taken part in another clinical trial. The study team will review your full medical background before you can join.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am a man aged between 30 and 65.
- I consider myself to be in good general health.
- I am not currently taking regular prescription medicines.
- I am willing to attend a clinical facility and possibly stay overnight.
- I have not taken part in another clinical trial in the last few months.
What does participation involve?
Taking part usually involves visiting a specialised clinical research unit. Before anything begins, you will attend a screening appointment where doctors check your medical history, perform a physical examination, take blood and urine samples, and run heart traces (ECGs). If you qualify, you will be given the study treatment, which might be a tablet, liquid, or injection. You may need to stay at the clinic for one or more nights so staff can monitor you closely and take regular blood samples to see how the medicine moves through your body. After leaving the clinic, you will likely need to attend one or more follow-up visits to ensure you remain well. The exact length of the study will be explained by the clinic team.
Potential risks and benefits
Locations (1)
- Quotient Sciences LimitedCity onlyNottingham, England
Common questions
What does 'deferred registration' mean?
It means the researchers have permission to delay publishing full scientific details online for a short time to protect commercial ideas. The study still follows all standard UK safety and ethics laws.
Do healthy volunteers get paid for taking part?
Most Phase 1 trials offer payment to compensate volunteers for their time, travel, and any inconvenience. The study team can give you exact figures.
Can I leave the study if I change my mind?
Yes. Taking part is completely voluntary. You can withdraw your consent and leave the study at any time without any penalty.
Why are only men aged 30 to 65 eligible?
Early trials often test specific age and sex groups to keep results consistent and reduce unknown risks before opening trials to wider groups.
How is my safety protected during the trial?
Doctors and nurses monitor you closely throughout the trial with regular tests. The study is also reviewed by an independent UK Research Ethics Committee before it starts.
How to find out more
Global Clinical Operations
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.